A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

Pfizer Requests Adjustment to Storage Temperatures From the FDA


Pfizer, maker of one of the two currently approved COVID-19 vaccinations, has asked the United States Food and Drug Administration (FDA) to adjust its vaccine’s required storage temperature from -112°F to -76°F to -13°F to -5°F. The new temperature range is provided by traditional pharmaceutical freezers and refrigerators, whereas the colder range requires a special subzero freezer. Pfizer asserts that the vaccine can be safely stored between -13°F and -5°F for up to 2 weeks. The pharmaceutical company has provided the FDA with additional data demonstrating the safety of such a move. If the FDA approves, the change would simplify the distribution process for the Pfizer vaccine. Click here to read more.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy